We came across a bullish thesis on Regeneron Pharmaceuticals, Inc. on Notes From The Beauty Contest’s Substack by Crashkolnikov. In this article, we will summarize the bulls’ thesis on REGN. Regeneron Pharmaceuticals, Inc.’s share was trading at $750.11 as of December 1st. REGN’s trailing and forward P/E were 18.70 and 18.52 respectively according to Yahoo Finance.
wavebreakmedia/Shutterstock.com
Regeneron Pharmaceuticals (REGN) reported its third-quarter earnings, again...
